Chandler Robinson

Chandler Drew Robinson is the founder of Monopar Therapeutics, Inc. (founded in 2014) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of Tactic Pharma LLC (founded in 2010) where he holds the title of Manager.
Currently, Dr. Robinson is the Director at Chemistry of Life Processes Institute.
In the past, he has worked as a Director at Wilson Therapeutics AB, Wilson Therapeutics, Inc., and Onyx Pharmaceuticals, Inc. He also held the position of Co-Manager-Healthcare Clinic at Onyx Pharmaceuticals, Inc. Prior to that, he worked as the President at The Bear Stearns Cos.
LLC.
Dr. Robinson's education includes a doctorate from Stanford University, an MBA from the University of Cambridge, an undergraduate degree from Northwestern University, and a graduate degree from the London School of Economics & Political Science.